Megestrol Acetate
NDC Package 50383-859-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Megestrol Acetate is megestrol is used to treat loss of appetite and weight loss in people with AIDS. Marketed by Akorn, this product is identified by NDC 50383-859 and is authorized under FDA application ANDA203960.

Identification & Billing

NDC Package Code
50383-859-22
Package Description
10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-859-20)
Product Code
11-Digit Billing Format
50383085922

Clinical Specifications

Proprietary Name
Megestrol Acetate
Dosage Form
-
Usage Information
Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone.

Regulatory & Marketing

Labeler Name
Akorn
FDA Application #
ANDA203960
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-10-2017
End Marketing Date
10-17-2025
Listing Expiration
10-17-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50383-859). Click a package code to view its specific billing and regulatory data.

4 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (50383-859-10)
10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (50383-859-10)
4 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (50383-859-20)
1 BOTTLE in 1 CARTON / 240 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50383-859-22 identifies a specific commercial package of 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 20 ml in 1 cup, unit-dose (50383-859-20) of Megestrol Acetate, labeled by Akorn. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Akorn on April 10, 2017. The current certification is valid through October 17, 2025.

What are the primary indications for this medication?

Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone.

How is this Akorn product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50383085922. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50383-859-22
11-Digit CMS (5-4-2)
50383-0859-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.